Crestwood Advisors Group LLC Buys 189 Shares of The Cigna Group (NYSE:CI)

Crestwood Advisors Group LLC increased its stake in shares of The Cigna Group (NYSE:CI) by 13.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,553 shares of the health services provider’s stock after buying an additional 189 shares during the period. Crestwood Advisors Group LLC’s holdings in The Cigna Group were worth $538,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Rehmann Capital Advisory Group bought a new position in The Cigna Group during the 1st quarter worth $268,000. Larson Financial Group LLC boosted its holdings in The Cigna Group by 198.8% in the 1st quarter. Larson Financial Group LLC now owns 245 shares of the health services provider’s stock valued at $89,000 after purchasing an additional 163 shares during the period. CFO4Life Group LLC acquired a new position in shares of The Cigna Group during the 1st quarter worth approximately $735,000. Empirical Finance LLC increased its holdings in shares of The Cigna Group by 3.2% during the first quarter. Empirical Finance LLC now owns 11,155 shares of the health services provider’s stock worth $4,051,000 after purchasing an additional 347 shares during the period. Finally, Envestnet Portfolio Solutions Inc. raised its position in shares of The Cigna Group by 20.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 26,921 shares of the health services provider’s stock valued at $9,777,000 after buying an additional 4,525 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the sale, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.70% of the stock is owned by corporate insiders.

The Cigna Group Trading Down 1.0 %

Shares of CI stock opened at $315.09 on Thursday. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83. The stock’s fifty day simple moving average is $343.37 and its 200 day simple moving average is $340.80. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $87.64 billion, a P/E ratio of 29.73, a P/E/G ratio of 0.96 and a beta of 0.51.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The company had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same quarter in the prior year, the firm posted $6.77 earnings per share. The firm’s revenue was up 29.8% compared to the same quarter last year. As a group, sell-side analysts predict that The Cigna Group will post 28.48 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a $1.40 dividend. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.78%. The Cigna Group’s payout ratio is 52.83%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CI shares. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday. Jefferies Financial Group increased their target price on The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a report on Tuesday, September 17th. JPMorgan Chase & Co. boosted their price target on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. Deutsche Bank Aktiengesellschaft cut their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research report on Monday. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, The Cigna Group presently has a consensus rating of “Buy” and a consensus price target of $394.64.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.